On ECHEMI
Home > Drugs > Guangdong Daxiang Pharmaceutical Co., Ltd.
Guangdong Daxiang Pharmaceutical Co., Ltd.
  • Founded in:

    2011-03-08
  • Country:

    China China
  • Address:

    Yuanmei Village, Shitan Town, Zengcheng District, Guangzhou (Pomegranate Base)
  • Tax NO.:

    91440183569775273G
  • Registered Funds:

    112 million yuan
  • Email:

Related Drugs
Sodium Chloride Injection
The main ingredients of this product and its chemical name: Sodium chloride
Name Description Content CAS NO. Registered Holders
Sodium chloride

Sodium chloride is an electrolyte supplement. Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining normal blood and extracellular fluid volume and osmotic pressure. The normal serum sodium concentration is 135-145mmol/L, accounting for 92% of plasma cations and 90% of total osmotic pressure, so the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum chloride concentration is 98-106mmol/L. Sodium and chloride ions in the human body are mainly regulated by the hypothalamus, posterior pituitary and kidneys to maintain the stability of body fluid volume and osmotic pressure.

More

Sodium chloride is an electrolyte supplement. Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining normal blood and extracellular fluid volume and osmotic pressure. The normal serum sodium concentration is 135-145mmol/L, accounting for 92% of plasma cations and 90% of total osmotic pressure, so the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum chloride concentration is 98-106mmol/L. Sodium and chloride ions in the human body are mainly regulated by the hypothalamus, posterior pituitary and kidneys to maintain the stability of body fluid volume and osmotic pressure.

7647-14-5 43
Glucose injection
The main component of this product is glucose. Its chemical name is D-(+)-pyranose glucose-hydrate.
Name Description Content CAS NO. Registered Holders
GLUCOSE

Caloric supplementation, treatment of hypoglycemia, used with insulin to treat hyperkalemia, rapid intravenous push of hypertonic glucose injection to dehydrate tissues, maintain and regulate the osmotic pressure of peritoneal dialysis fluid

More

Caloric supplementation, treatment of hypoglycemia, used with insulin to treat hyperkalemia, rapid intravenous push of hypertonic glucose injection to dehydrate tissues, maintain and regulate the osmotic pressure of peritoneal dialysis fluid

58367-01-4 14
Hydroxyethyl starch 40 sodium chloride injection
Hydroxyethyl starch 40.
Name Description Content CAS NO. Registered Holders
Hydroxyethyl starch

After intravenous infusion, this product stays in the blood for a long time, increasing plasma osmotic pressure, increasing tissue fluid reflux, rapidly increasing blood volume, diluting blood, and increasing the negative charge of cell membranes, causing aggregated cells to disaggregate, reducing systemic blood viscosity, and improving microcirculation.

More

After intravenous infusion, this product stays in the blood for a long time, increasing plasma osmotic pressure, increasing tissue fluid reflux, rapidly increasing blood volume, diluting blood, and increasing the negative charge of cell membranes, causing aggregated cells to disaggregate, reducing systemic blood viscosity, and improving microcirculation.

9005-27-0 6
Hydroxyethyl starch 40 sodium chloride injection
Hydroxyethyl starch 40.
Name Description Content CAS NO. Registered Holders
Hydroxyethyl starch

After intravenous infusion, this product stays in the blood for a long time, increasing plasma osmotic pressure, increasing tissue fluid reflux, rapidly increasing blood volume, diluting blood, and increasing the negative charge of cell membranes, causing aggregated cells to disaggregate, reducing systemic blood viscosity, and improving microcirculation.

More

After intravenous infusion, this product stays in the blood for a long time, increasing plasma osmotic pressure, increasing tissue fluid reflux, rapidly increasing blood volume, diluting blood, and increasing the negative charge of cell membranes, causing aggregated cells to disaggregate, reducing systemic blood viscosity, and improving microcirculation.

9005-27-0 6
Betahistine Hydrochloride and Sodium Chloride Injection
N-Methyl-2-pyridineethylamine dihydrochloride
Name Description Content CAS NO. Registered Holders
Betahistine dihydrochloride

Betahistine is a diamine oxidase inhibitor. It has a significant dilating effect on cerebrovascular and cardiovascular systems, especially on the conical artery system. It significantly increases the blood flow of the heart, brain and peripheral circulation, improves blood circulation, and lowers systemic blood pressure. In addition, it can increase the blood flow of the cochlea and vestibule, thereby eliminating inner ear vertigo, tinnitus and ear closure. It can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema. It can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and it has the effect of inhibiting blood coagulation and ADP-induced platelet aggregation, it can prolong the time of thrombosis in vitro in rats, and it also has a slight diuretic effect.

More

Betahistine is a diamine oxidase inhibitor. It has a significant dilating effect on cerebrovascular and cardiovascular systems, especially on the conical artery system. It significantly increases the blood flow of the heart, brain and peripheral circulation, improves blood circulation, and lowers systemic blood pressure. In addition, it can increase the blood flow of the cochlea and vestibule, thereby eliminating inner ear vertigo, tinnitus and ear closure. It can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema. It can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and it has the effect of inhibiting blood coagulation and ADP-induced platelet aggregation, it can prolong the time of thrombosis in vitro in rats, and it also has a slight diuretic effect.

5579-84-0 21
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.